Meeder Asset Management Inc Beyond Spring Inc. Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.02 - $16.84 $13,233 - $55,437	-3,292 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$9.26 - $31.31 $3,139 - $10,614	-339 Reduced 9.34%	3,292 $52,000
Q2 2021 Aug 09, 2021	BUY	$9.37 - $12.12 $16,003 - $20,700	1,708 Added 88.82%	3,631 $38,000
Q1 2021 Apr 28, 2021	BUY	$10.61 - $15.77 $20,403 - $30,325	1,923 New	1,923 $21,000
Q4 2020 Feb 09, 2021	SELL	$10.21 - $17.31 $22,901 - $38,826	-2,243 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$9.99 - $16.13 $1,048 - $1,693	105 Added 4.91%	2,243 $29,000
Q2 2020 Aug 11, 2020	BUY	$11.21 - $18.15 $19,752 - $31,980	1,762 Added 468.62%	2,138 $33,000
Q1 2020 May 15, 2020	SELL	$9.68 - $18.47 $37,403 - $71,368	-3,864 Reduced 91.13%	376 $5,000
Q4 2019 Feb 13, 2020	BUY	$11.83 - $18.68 $49,212 - $77,708	4,160 Added 5200.0%	4,240 $67,000
Q3 2019 Oct 17, 2019	BUY	$15.33 - $23.85 $1,226 - $1,908	80 New	80 $1,000

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.5M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.